Free Trial

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems logo
$223.18 +6.60 (+3.04%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
8
Buy
18

Based on 27 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 27 analysts, 1 has given a sell rating, 8 have given a hold rating, and 18 have given a buy rating for VEEV.

Consensus Price Target

$255.74
14.59% Upside
According to the 27 analysts' twelve-month price targets for Veeva Systems, the average price target is $255.74. The highest price target for VEEV is $307.00, while the lowest price target for VEEV is $192.00. The average price target represents a forecasted upside of 14.59% from the current price of $223.19.
Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

Sign Up

VEEV Analyst Ratings Over Time

TypeCurrent Forecast
1/22/24 to 1/21/25
1 Month Ago
12/23/23 to 12/22/24
3 Months Ago
10/24/23 to 10/23/24
1 Year Ago
1/22/23 to 1/22/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
18 Buy rating(s)
18 Buy rating(s)
16 Buy rating(s)
15 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$255.74$257.44$232.96$216.18
Forecasted Upside14.59% Upside14.85% Upside7.02% Upside3.28% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Veeva Systems Stock vs. The Competition

TypeVeeva SystemsMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.82
2.52
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside15.07% Upside24,994.89% Upside11.24% Upside
News Sentiment Rating
Positive News

See Recent VEEV News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/17/2025Needham & Company LLC
2 of 5 stars
Ryan MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$270.00 ➝ $270.00+25.76%
1/13/2025Truist Financial
2 of 5 stars
Jailendra Singh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$261.00 ➝ $210.00-2.66%
1/8/2025KeyCorp
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$285.00 ➝ $255.00+17.46%
12/20/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Garro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$280.00+27.46%
12/17/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$183.00 ➝ $195.00-12.60%
12/16/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$208.00 ➝ $218.00-4.23%
12/9/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$281.00 ➝ $307.00+22.77%
12/6/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$235.00 ➝ $240.00-4.80%
12/6/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$260.00 ➝ $275.00+9.86%
12/6/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$220.00 ➝ $245.00-4.09%
12/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$280.00 ➝ $290.00+13.44%
12/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$275.00 ➝ $285.00+12.20%
12/6/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$275.00 ➝ $285.00+23.03%
12/6/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$240.00 ➝ $272.00+17.41%
12/6/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$210.00 ➝ $270.00+16.55%
12/6/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$280.00 ➝ $290.00+25.18%
12/6/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$275.00 ➝ $283.00+22.16%
12/4/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Valiquette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Outperform$275.00 ➝ $275.00+21.44%
10/8/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Degasperi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$286.00+41.70%
10/1/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$233.00 ➝ $249.00+20.00%
8/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$180.00 ➝ $192.00-11.20%
8/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$230.00 ➝ $235.00+12.28%
8/26/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$185.00 ➝ $215.00+7.47%
7/9/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Larsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$240.00+31.21%
3/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$225.00 ➝ $270.00+21.62%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$219.00 ➝ $248.00+10.30%
2/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$225.00+2.46%
3/2/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform$215.00 ➝ $230.00+38.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:08 PM ET.


Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, January 19, 2025. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • Veeva Systems Inc. has received multiple upgrades from analysts, with price targets raised by firms like Bank of America and Royal Bank of Canada, indicating strong market confidence in the company's future performance.
  • The current stock price is $213.06, which is significantly lower than its 52-week high of $258.93, suggesting potential for price appreciation as the market stabilizes.
  • Insider ownership stands at 10.50%, which can be a positive indicator as it suggests that those with the most knowledge about the company have a vested interest in its success.
  • The company has a solid market capitalization of approximately $34.59 billion, which reflects its established presence and stability in the life sciences software sector.
  • Veeva Systems Inc. has a consensus rating of "Moderate Buy" from analysts, with a majority recommending the stock as a good investment opportunity.

Veeva Systems
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • Recent insider sales, including significant transactions by executives, may raise concerns about the company's short-term outlook and could indicate a lack of confidence among insiders.
  • Truist Financial recently lowered their price objective from $261.00 to $210.00, which may signal a bearish sentiment and potential challenges ahead for the company.
  • The stock has experienced volatility, with a recent trading down of 2.2%, which could deter risk-averse investors looking for stable investments.
  • Despite a strong market presence, Veeva Systems Inc. operates in a competitive industry, which may pose risks to its growth and profitability.
  • The company's high P/E ratio of 52.61 suggests that the stock may be overvalued compared to its earnings, which could lead to price corrections in the future.

VEEV Forecast - Frequently Asked Questions

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $255.74, with a high forecast of $307.00 and a low forecast of $192.00.

27 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There is currently 1 sell rating, 8 hold ratings and 18 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VEEV shares.

According to analysts, Veeva Systems's stock has a predicted upside of 14.59% based on their 12-month stock forecasts.

Analysts like Veeva Systems less than other "medical" companies. The consensus rating score for Veeva Systems is 2.63 while the average consensus rating score for "medical" companies is 2.82. Learn more on how VEEV compares to other companies.


This page (NYSE:VEEV) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners